Bristol-Myers Squibb

Bristol-Myers Squibb turns to DTC to promote Opdivo
Medical Marketing and Media
Thu, 10/29/15 - 06:17 pm
Bristol-Myers Squibb
DTC
Opdivo
Merck's Keytruda has a shot at a bigger share of NSCLC sales
Fierce Pharma Marketing
Wed, 10/28/15 - 02:59 pm
Merck
Keytruda
non-small cell lung cancer
Opdivo
Bristol-Myers Squibb
Bristol cancer, clot drugs drive profit beat, shares rise
Yahoo/Reuters
Tue, 10/27/15 - 09:28 am
Bristol-Myers Squibb
earnings
4 Blockbuster Drugs Whose Sales Could Easily Double
Motley Fool
Mon, 10/26/15 - 08:46 am
Xtandi
Medivation
Astellas
Eliquis
Pfizer
Bristol-Myers Squibb
Revlimid
Celgene
Invokana
JNJ
Bristol-Myers Squibb Offers Healthy Doses of Growth and Value Ahead of Earnings
TheStreet.com
Mon, 10/26/15 - 08:32 am
Bristol-Myers Squibb
earnings
J&J's Earnings May Be Good News for Bristol-Myers Squibb and Medivation
Motley Fool
Mon, 10/19/15 - 09:39 am
JNJ
earnings
Bristol-Myers Squibb
Medivation
Opdivo expansion may displace Keytruda
Medical Marketing and Media
Sat, 10/17/15 - 03:15 pm
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Bristol-Myers, Five Prime enter licensing deal of up to $1.74 bln
Yahoo/Reuters
Thu, 10/15/15 - 08:44 am
Bristol-Myers Squibb
Five Prime
FPA008
cancer immunotherapy
Who's Up Next? More Pharma Companies Expected To Settle Foreign Bribery Cases
Forbes
Wed, 10/14/15 - 02:15 pm
FCPA
bribery
GSK
Bristol-Myers Squibb
Teva Pharmaceutical
Sanofi
AstraZeneca
UCB Pharma
Novartis
Novo Nordisk
Eli Lilly
Bristol-Myers' Opdivo Gets Another Early Approval
Investors.com
Sun, 10/11/15 - 01:52 pm
Opdivo
Bristol-Myers Squibb
non-squamous lung cancer
FDA
Bristol-Myers' Opdivo Gets Another Early Approval
Investors.com
Sun, 10/11/15 - 01:52 pm
Opdivo
Bristol-Myers Squibb
non-squamous lung cancer
FDA
Can Daklinza profit from a set of niche hep C uses? BMS may soon find out
Fierce Pharma Marketing
Wed, 10/7/15 - 10:00 am
Daklinza
Bristol-Myers Squibb
hepatitis C
Bristol-Myers pays $14M to settle charges of paying bribes in China
Pharmalot
Mon, 10/5/15 - 06:04 pm
China
Bristol-Myers Squibb
bribery
Keytruda's label confers edge for Opdivo
Medical Marketing and Media
Mon, 10/5/15 - 06:02 pm
Keytruda
Opdivo
Merck
Bristol-Myers Squibb
PDL-1 inhibitors
Kidney Cancer Drug Boxing Match
Motley Fool
Mon, 10/5/15 - 09:17 am
kidney cancer
Bristol-Myers Squibb
Novartis
Exelixis
Opdivo
Cometriq
Afinitor
How can Pradaxa, Xarelto and Eliquis finally unseat warfarin? Safety data, analyst says
Fierce Pharma
Thu, 10/1/15 - 05:29 pm
Pradaxa
Xarelto
Eliquis
bloodthinners
Warfarin
drug safety
JNJ
Boehringer Ingelheim
Pfizer
Bristol-Myers Squibb
Bristol-Myers Cancer Drug Combination to Cost $256,000 a Year
Bloomberg
Thu, 10/1/15 - 02:16 pm
Bristol-Myers Squibb
Opdivo
Yervoy
drug pricing
melanoma
skin cancer
FDA approves Bristol-Myers drug combination for skin cancer
Yahoo/Reuters
Thu, 10/1/15 - 09:22 am
FDA
Bristol-Myers Squibb
skin cancer
Opdivo
Yervoy
Which Big Pharma Will Grab the Lion’s Share of the Cancer Immunotherapy Market?
Motley Fool
Wed, 09/30/15 - 07:59 pm
cancer immunotherapy
Juno Therapeutics
Kite Pharma
Celgene
Bluebird Bio
AstraZeneca
Pfizer
Bristol-Myers Squibb
Bristol-Myers, J&J Upgraded On New Drug Prospects
Investors.com
Tue, 09/29/15 - 10:27 pm
Bristol-Myers Squibb
JNJ
Imbruvica
Opdivo
daratumumab

Pages